Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade

Abstract

Abstract A 69‐year‐old man with non‐small cell lung cancer presenting with pericardial effusion and rapid progression of dyspnea achieved long‐term disease stabilization after radiation therapy and immunotherapy. This case shows that pembrolizumab may improve prognosis in advanced lung cancer, even when complicated by cardiac tamponade.

Keywords

• cardiac tamponade
• immunotherapy
• non‐small cell lung cancer
• pembrolizumab
• radiotherapy